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1. Introduction 
Acquired and congenital abnormalities of the lower urinary tract often require eventual 
reconstruction. Traditionally, different types of autologous tissue can be chosen for surgery, 
depending on which organ requires reconstruction. Bladder reconstruction, for example, is 
usually performed with intestinal tissue while urethral reconstruction can us buccal mucosa, 
lingual mucosa, colonic mucosa or prepuce skin. However, the problems of a shortage of 
patients’ own tissues, and of nmany complications related to surgery, have not yet been 
resolved. There is therefore an effort to obtain sufficient tissue resources, to involve fewer 
complications, to reduce surgery to relatively minor invasion and to achieve better surgical 
outcomes. These goals may be attainable by the use of tissue engineering techniques. 
Over the last 50 years, tissue engineering techniques for low urinary tract regeneration have 
been applied successfully in a variety of animal models and clinical patients. Rapid 
advancement has been made in this field, which has broadened the theoretical options for the 
future of low urinary tract reconstruction. These developments include improvements in cell 
culture techniques, such as the development of cell resources and identification of markers to 
isolate and characterize specific cell types. Many new types of natural and synthetic 
biomaterials for use as scaffold components have been created (1). In addition to these, the 
applications of nanotechnology and bioreactors have been strengthened within recent decades. 
Here, we review the literature on the basic principles and latest developments of tissue 
engineering technologies in lower urinary tract reconstruction. 
2. Basic knowledge of tissue engineering in low urinary tract 
2.1 Cell sources 
2.1.1 Autologous stromal cells 
Because epithelial cells are one of the most important components of the lower urinary tract, 
optimizing sources for them have always been a popular focus of investigators. 
Traditionally, urothelial cells obtained from bladder or urethra have often been used in 
previous studies (Fig 1a) (2,3). Although this technique exploits homotypy between the graft 
cells and host, it involves injury to the genitourinary tract and the operation is complicated. 
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Fu, et al. chose epidermal cells as graft cells because of its abundant resources; they can be 
obtained by a less invasive method than the traditional method of bladder or urethral 
biopsy followed by dissection of transitional cells. The results suggest that the epidermal 
cells can transform to transitional epithelial cells under the influence of the urethral or 
bladder environment (4). From our experience, we suggest using the oral keratinocytes, such 
as buccal keratinocytes and lingual keratinocytes, as a source of epithelial cells, (Fig 1b,c). 
Such cells express the -defensin, IL-8, which can mediate an innate immune response 
against microbes (5). Therefore, compound grafts were easily resisted infection both in vitro 
and in vivo. In addition, these oral keratinocytes expressed AE1/AE3, which is similar to 
epidermal cells or urothelial cells in a previous report (6). However, 3T3 cells are usually 
needed as a feeder layer when culturing oral keratinocytes. The purification of oral 
keratinocytes therefore needs to be should be improved before clinical application. 
   
Fig. 1. Morphology the different kinds of epithelial seeding cells. 
a. Bladder urethelial cells; b. buccal keratinocytes; c. lingual keratinocytes 
To construct 3D bladder or urethral tissue, smooth muscle cell is also necessary. Previously, 
bladder smooth muscle cells were used for tissue engineering bladder reconstruction (Fig2a). 
The corpora cavernosa smooth muscle cells were used for constructing the corpora 
spongiosum, which is one of the most important components of the penile urethra (Fig2b). The 
advantage of using those cells is that some angiogenic growth factors and their receptors, such 
as Flk-1 and VEGF, are present in smooth muscle cells. They might contribute to the 
angiogenesis of bladder or urethral tissue (7). Since contamination by fibroblast cells is a  
  
Fig. 2. Morphology the different kinds of smooth muscle cells. 
a. Bladder smooth muscle cells; b. corpora cavernosa smooth muscle cells 
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problem during culturing of these, we advise that a velocity sedimentation method be used 
to evaluate the purification of smooth muscle cells. Of course, obvious trauma after the 
procedure is also the shortcoming of this method. As a result of these problems, smooth 
muscle cells are being replaced by muscle stem cells in urinary reconstruction. 
2.1.2 Bone marrow and adipose derived stem cells 
Stem cells from bone marrow (BMSC) have been characterized as being either hematopoietic 
or mesenchymal. They are easily isolated due to their affinity with and adherence to plastic 
dishes. Their ability to proliferate ensures that even a small number of BMSC multiply into 
millions of cells under the right culture conditions. Another merit of these cells is that they 
do not express MHC II, rendering them nonimmunogenic and thereby eliminating possible 
graft rejection (8). Previous studies showed that BMSCs contained higher concentrations of 
-SM actin than did bladder SMC. Meanwhile, BMSCs showed strong response to the Ca2+-
ionophore, whereas fibroblasts did not contract their baseline even in the presence of 
calcium. Those results indicate that BMSCs and smooth muscle cells from low urinary tract 
are very similar (9). Therefore, BMSCs may serve as an alternative cell source in lower 
urinary tract tissue engineering.  
Stem cells from adipose tissue (ADSCs) have also been popular in tissue engineering 
research. Adipose tissue is derived from embryonic mesodermal precursors and it contains 
multipotent progenitor cells that are capable of differentiating into mesenchymal tissue. 
Since adipose tissue contains 100-1,000 times more pluripotent cells per cubic centimeter  
 
Fig. 3. Myogenic differentiation of human BMSCs using SMC-derived CM. Human 
BMSCs (p4) were stained with a-SMA (a, e, i), calponin (b, f, j), desmin (c, g, k), and 
myosin (d, h, l) antibodies without induction as negative control (a–d) and with induction 
for 14 days (e–h). SMCs were also stained with the same antibodies as a positive control 
(i–l). (Picture from ref 11) 
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than does bone marrow, it is easier to obtain ADCSs than other kinds of adult stem cells. Of 
course, immunoprivilege is also the advantage of this kind of cell. For these reasons, many 
investigators have selected ADSCs as an ideal source of seeding cells in lower urinary 
reconstruction, such as repair of bladder and urethra (10). 
In many studies, mesenchymal cells have been found to differentiate into many different 
lineages, such as chondrocytes, osteoblasts, adipocytes, neurons and myoblasts. To 
urologists, the most interesting thing is the possibility for differentiation of BMSCs or 
ADSCs into smooth muscle cells and keratinocytes. According to previous reports, these 
stem cells can acquire a smooth muscle cell phenotype, staining positively for -SMA, 
myosin and calponin after being cultured in conditioned medium. Also, culturing in the 
presence of other myogenic growth factors, such as PDFF-BB,HGF,TGF-, can also lead to a 
phenotypic profile of smooth muscle cells (Fig 3) (8,11). Another group has demonstrated 
the differentiation of marked BMSC into urothelial cells on a seeded scaffold in porcine 
bladder augmentation, suggesting that mesenchymal stem cells can be made into urothelial 
cells. However, few additional reports support this result. Since the BMSCs and ADSCs are 
derived from the mesodermal lineage, more evidence is needed to support that ectodermal 
lineage cells can be induced from mesenchymal stem cells, such as BMSCs and ADSCs. 
2.1.3 Other seeding cells 
As well as the autologous stromal cells, BMSCs and ADSCs, other kinds of seeding cells 
have also shown possibilities for lower urinary tract reconstruction. Drewa (12) et al. used 
hair follicle stem cells for bladder regeneration in rats. This type of cell is CD34 positive, 
which facilitates the isolation of live epithelial cells with stem cell characterisitcs. In their 
study, Drewa et al. concluded that pluripotent stem cells within rodent hair follicle can 
differentiate into neurons, glia, keratinocytes and smooth muscle cells. They used an 
acellular matrix seeded with those cells and achieved a successful bladder wall 
reconstruction. Further research should be focused on better characterization of these cell 
populations and on the exact mechanism by which these cells enhance bladder 
regeneration. 
Zhang’s study focused on a subpopulation of cells isolated from naturally voided urine 
(13). This kind of cell demonstrated features typical of progenitor/stem cells, including 
expression of MSC and pericyte cell surface markers and clonogenic, multipotential, and 
plastic adhensive capacity. Furthermore, recent study showed that these cells have the 
capability to differentiate into the urothelial and smooth muscle cells (Fig 4)(14). The 
latest study has demonstrated the feasibility of forming a tissue-engineered conduit for 
use in urinary diversion by generating scaffolds seeded with human urine-derived stem 
cells. 
Other cells, such as human amniotic fluid stem cells (AFS), human embryonic stem cells (ES) 
and human induced pluripotent stem cells (iPS), have also shown a potential for application 
in lower urinary reconstruction. However, most reports have been rather preliminary 
investigations. Several key points still need to be studied in depth before the cells can be 
used in patients. 
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Fig. 4. Morphology of urine-derived stem cells obtained from upper urinary tract  
(USC-UUT) with differentiation. a. non-treated USC; b. The shape of -UUT changed from an 
oval to a spindle shape with the addition of myogenic medium; c. a cuboidal shape with the 
addition of uro-epithelial medium. Scale bar shown is 100 mm (Picture from ref 14). 
2.2 Biomaterials 
Creating an ideal biomaterial for lower urinary tract reconstruction has been an aspiration of 
urologists for over a century. An excellent biomaterial for tissue engineering should possess 
optimal mechanical properties, good biocompatibility, suitable three dimensional structures 
and degradation rates (15).  
2.2.1 Traditional biomaterials 
Traditionally, biomaterials can be classified into naturally derived materials, including 
chitosan, collagen; acellular matrix , such as small intestine submucosa (SIS), bladder 
acellular matrix (BAMG), acellular corpous spongious matrix (ACSM) and urethral extra 
matrix (UEM) , as well as synthetic materials, such as PGA and PLGA. Most of them have 
been used in animal models and human subjects, which will be discussed in the later 
section. Brehmer provides a useful classification of scaffolds into carrier-, fleece- and 
sponge-types, according to the structure of biomaterials (16) Carrier-type scaffolds are fiber 
meshes with very small pore sizes (<15 m). The pore size of the sponge-type scaffolds is 
greater than 15 m. Fleece-type scaffolds have huge interfilamentary spaces (200 m). In our 
previous study, we compared the dimensional structures of SIS, BAMG, handmade PGA 
mesh and ACSM. SEM demonstrated that the pore size of the PGA (>200 m) was the 
largest among all biomaterials. The surface pore sizes in SIS were significantly larger than 
BAMG (58.32 ± 10.31 m vs 6.77 ± 0.49 m; P < 0.05). Although a looser structure of BAMG 
could be seen with H&E staining, its pore sizes in surface views were smaller than those of 
ACSM (6.77 ± 0.49 m vs 11.12 ± 1.43 m; P < 0.05). An obvious difference of pore diameters 
in ACSM could be distinguished between urethral surface and cavernosal surface. (2.04 ± 
0.32 m vs 11.12± 1.43 m; P< 0.05)(Fig 5)(17). This data can guide the following cell seeding 
procedure, since cellular growth and infiltration are strongly related to the scaffold’s pore 
sizes. Of course, it should be noted that the structure of PGA or PLGA can be controlled 
now with the development of electrospin techniques. Therefore, the dimensional structure 
of synthetic materials is becoming more similar to the naturally derived scaffolds, and even 
to the original organs. 
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Fig. 5. EMS examination of different materials’ surface. (A) urethral surface of ACSM, 
EMS×5,000, (B) cavernosal surface of ACSM,EMS×5,000 (C) surface of BAMG, 
EMS×5,000. (D) surface of SIS, EMS_200. (E) surface of PGA, EMS×200. 
 
Fig. 6. Metabolic activity of CCSMCs cultured with extracts of various biomaterials or 
cultured directly in normal medium at 1, 3, 8, and 10 days, as determined by MTT assays. 
The difference between biomaterials and negative controls was not statistically significant 
To address the issue of biocompatibility, our study used the MTT assay technique to 
evaluate cytotoxicity of different kinds of biomaterials. There were no statistically significant 
differences in MTT results between the cells cultured with biomaterial extracts and with 
controls (Fig 6). Thus, we may suggest that all scaffolds could be used safely for lower 
urinary tract reconstruction. 
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The mechanical properties of biomaterials are also key to successful reconstruction of the 
lower urinary tract. For urethral reconstruction, a uniaxial mechanical test is necessary to 
evaluate the scaffold. In our previous study, all biomaterials exhibited the classic biological 
nonlinear stress–strain response (Fig. 7) in a mechanical test. The ACSM showed good 
response in Young’s modulus and breaking stress, these being better than in other scaffolds, 
even the normal rabbit urethra. For the bladder, physiological loading of the tissue involves 
compressive loads perpendicular to the bladder surface, induced by urine and surrounding 
pelvic tissues, so biaxial mechanical testing is more realistic. In addition, a burst experiment 
should also be considered (18) (Fig 8) 
 
Fig. 7. Stress–Strain curves of various biomaterials. (A) Normal rabbit urethra; (B) SIS;  
(C) 4-layer SIS; (D) BAMG; (E) ACSM; (F) PGA 
 
Fig. 8. Picture of ball-burst test with a ruptured test material. Arrow points at the rupture 
site from (ref 18) 
2.2.2 Modified & advanced biomaterials 
Since inherit weaknesses always exist in traditional biomaterials, many modified 
biomaterials have been studied to avoid them.  
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To enhance angiogenesis, some investigators have modified traditional matrices by 
incorporating heparin and subsequently loading the heparinized matrices with VEGF. 
Preliminary studies have shown that this loading of the matrices with VEGF increases the 
induction of microvessels in both heparinized and non-heparinized matrices, the effect 
being largest in the case of the heparinized matrices (19). 
In order to control the three dimensional structure and degradation rate of synthetic 
scaffolds such as PGA or PLGA, electrospin techniques are often considered for tissue 
engineering in lower urinary tract reconstruction. Various materials have been examined for 
their ability to support cellular adhension, proliferation and formation of a multilayerd 
urothelium. The results provide the evidence that electrospinning scaffolds show significant 
benefitsa over commonly used acellular materials in vitro, and suggest that they should be 
further examined in vivo (20). 
2.3 Advanced technique 
2.3.1 Bioreactor 
The bioreactor is a device that provides a fluid environment for the growth of cells for 
various applications, such as industrial fermentation and cell culturing. Bioreactors should 
be introduced in tissue engineering to optimize, through fluid shear, oxygenation and the 
supply of nutrients, the growth of cells on a 3D scaffold. This approach has been shown to 
result in better tissue-like constructs than do conventional static culture conditions (21). It is 
possible to use in vivo graft sites as ‘bioreactors’ that feature flowing fluids (blood). An 
example that is commonly used in tissue engineering for lower urinary reconstruction is the 
greater omentum. Baumert et al (21) used urothelial and smooth muscle cells to seed a 
sphere-shaped small intestinal submucosa matrix, which was transferred into the omentum 
after 3wk of cell growth. By this approach, they obtained tissue engineered bladder with a 
wall thickness was 4 mm. The construct presented a multilayer urothelium on the lumial 
aspect and deeper fascicles of organized tissue composed of differentiated smooth muscle 
cells and mature fibroblasts. There was no evidence of inflammation or necrosis (Fig 9). Gu 
et al (22) implanted 8Fr silastic tubes into the peritoneal cavity of a rabbit. Those tubes were 
harvested and the tubular tissue covering the tubes was reverted. A pendulous urethral 
segment of 1.5 cm long was totally excised and urethroplasty was performed with the 
reverted tubular tissue in an end-to-end fashion. Finally, the results of study showed that 
the recipients’ peritoneal cavity can be used as bioreactor for tissue engineering urethral 
reconstruction. 
More manufactured bioreactors have been designed for tissue engineering bladder. In 
order to mimic the dynamics of the urinary bladder, bioreactors that imitate the filling 
and emptying of a normal bladder have been suggested. A bladder bioreactor built this 
way should be able to recapitulate those dynamics while providing a cellular 
environment that facilitates cell-cell and cell-matrix interactions. Under the mechanical 
stimulation from bioreactor, the physiological and mechanical properties of the bladder 
can be improved. The growth behavior of urothelial cells and bladder smooth cells can be 
changed, resulting in the cells undergoing adaptive changes in mechanically-stimulated 
environment (23, 24).  
www.intechopen.com
 
Tissue Engineering in Low Urinary Tract Reconstruction 
 
433 
 
 
Fig. 9. Harvesting of the matured construct 3 wk after implantation in the omentum (ref 21) 
 
 
Fig. 10. a. Disassembled urinary bladder bioreactor. I. This chamber will be subjected to 
controlled pressure and hence would mimic in vitro the urinary bladder chamber. II. Tissue 
engineered construct ring. III. Compliance chamber (cell culture medium will be re-
circulated to accommodate the expansion of the scaffold upon pressure generation).  
b Interlocking discs for cell-seeded scaffold. c Assembled bioreactor (ref 23) 
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Fig. 11. The bioreactor system. A: A diagram of the disassembled bioreactor, showing the  
2 pressure chambers and 2 culture chambers, separated by 3 interlocking rings with elastic 
membrane. Every interlocking ring was 2 interlocking disks that hold the cell-seeded 
membrane, which was glued by -cyanoacrylate. B: The assembled bioreactor with the 
ports, to which tubing would be attached for medium flow and pressure monitoring. The 
red parts are culture chambers, blue parts are pressure chambers. C: The assembled culture 
chambers, the dashed frame showing the pressure P1 and P2 on both sides of cell-seeded 
membrane. the elastic membrane deformation was driven by pressure difference (P1-P2). 
(ref 24) 
2.3.2 Nanotechnology 
Nanotechnology has largely emerged in the last decade of the 20th century as a potential 
new enabling technology for medicine. For bladder reconstruction, this technology provides 
a new set of tools to solve many problems that may encountered during the reconstructive 
procedure. Especially, the incorporation of nanotechnology into bladder tissue engineering 
materials provides for better bladder materials. Recent published work has demonstrated 
that increasing of material surface roughness at the nanoscale can improve the adsorption of 
select proteins important for bladder cell functions (25). Furthermore, some reports showed 
more bladder smooth muscle cell attachment and growth on polystyrene nanofiber scaffolds 
fabricated, using an electrospinning technique, to possess surface features at the nanoscale. 
Cellular adhesive and proliferative ability of keratinocytes were also improved in the 
nanoscaled scaffold (26).(Table1) 
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As well as the electrospinning technique mentioned above, another useful nanotechnique is 
the use of nanoparticles as a delivery system. Mondalek et al (27) investigated the use of 
PLGA nanoparticles to alter the permeability of SIS scaffolds. Preliminary results indicated 
that particles ranging from 200 to 500 nm would become imbedded in the SIS scaffold. 
Particles below this size range would pass through the graft and not become entrapped, and 
particles above this size range could not penetrate the scaffold. Those results provided the 
possibility of using nanoparticles to deliver growth factors into seeded cells and scaffolds, to 
enhance the regeneration of lower urinary tract. 
 
Table 1. Nanotechnology Approaches to Increase Bladder Cell Functions (ref 26) 
2.3.3 Oxygen generating scaffolds 
The limitation of oxygen diffusion has led to the general concept that cell or tissue 
components may not be implanted in large volumes. Many efforts have been made to 
overcome this limitation. Recently, implantable oxygen releasing biomaterials have been 
developed in order to provide a sustained release of oxygen to cells and tissues with the 
goal of prolonging tissue survival and decreasing necrosis (28). In those studies, an oxygen 
rich compound of sodium percarbonate or calcium peroxide was incorporated into films or 
3D constructs of PLGA and used for in situ production of oxygen. In vitro, release of oxygen 
could be observed from the film more than 24h. Furthermore, these biomaterials were able 
to extend cell viability growth under hypoxic conditions. Those findings indicate that the 
use of oxygen generating biomaterials may enhance the scaffold neovascularization after 
implantation (29). All results suggested that oxygen generating scaffolds can be used for 
lower urinary tract reconstruction in the future.  
3. Applications of tissue engineering in the lower urinary tract 
3.1 Bladder reconstruction 
Congenital disorders, cancer or trauma can lead to obvious bladder damage. For patients 
with these problems, bladder reconstructive procedures may be considered. Although 
gastrointestinal segments are commonly used for bladder augmentation or replacement, 
multiple complications cannot yet be completely avoided; they include infection, metabolic 
disturbance and ureolithiasis. A number of animal studies and even clinical experiences 
have, however, shown the possibility of using tissue engineering techniques to reconstruct 
bladder tissue. In the laboratory, tissue could be engineered to have function equivalent to 
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the original tissue. In the clinic, patients provided with engineered bladder tissue have 
obtained satisfactory results. 
3.1.1 Animal experiments 
Since 1955, many investigators have tried to use different kinds of scaffold for bladder 
reconstruction in animal models; these have included polyvinyl sponges, polyethylene 
moulds, Teflon, gelatin sponges, and decellularized pericardial tissue. The outcomes in most 
studies were unsatisfactory (30). One really successful experiment was reported by Kropp 
BP et al. (31) in 1995. In this study, the rat underwent partial cystectomy with immediate 
bladder augmentation with SIS. Host cellular infiltration into the scaffold could be seen 2 
weeks after operation. By the end of 48 weeks, the SIS graft presented the three-layered 
structure of normal bladder, which was indistinguishable from the original bladder. This 
preliminary study demonstrated the feasibility of using an optimal tissue engineering 
scaffold for bladder reconstruction. Further study has shown that muscarinic, purinergic 
and functional cholinergic innervation occurred in rats (32). More recently, bladder 
regeneration has shown to be more reliable when the SIS was derived from the distal ileum 
(33). However, graft contraction could be observed in large animal models after using SIS 
for bladder augmentation, which means that pre-seeding cells may be necessary for tissue 
engineering-based bladder reconstruction in humans. 
Zhang et al. first seeded human bladder urothelial cells and smooth muscle cells onto the 
SIS by a sandwich culture method (34). This kind of seeding method resulted in organized 
cell sorting, formation of a well-defined pseudostratified urothelium and multilayered 
smooth muscle cells with enhanced matrix penetration (Fig 12). The initial study 
demonstrated that using SIS combined with cell culture could be a valuable model for the 
study of tissue engineering in bladder reconstruction. To address the problem of graft 
contraction, Brown et al. showed that opposite-side co-culture of smooth muscle cells and 
epithelial cells produced a less pronounced matrix contraction than same-side co-culture 
(20) (Fig 13). The other problem to be addressed in tissue engineering bladder in vitro is 
cellular infiltration. Recently, Liu et al used preacetic acid (PAA) and Triton X-100 
  
Fig. 12. Sandwich coculture at 28 days shows similar growth pattern to layered coculture 
technique except that urothelial cells and smooth muscle cells are on opposite sides of small 
intestinal submucosa membrane. Pseudostratified layer of urothelium is on mucosal surface 
(open arrow) while multiple layers of smooth muscle cells are on serosal surface and are 
penetrating into matrix of small intestinal submucosa membrane (solid arrow)(ref 34)  
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Fig. 13. Gross appearance of cell seeded constructs at 7 and 28 days post seeding. (A) 
Collagen Gels, 7 days. (B) BAM, 7days. (C) Collagen Gels, 28 days. (D) BAM, 28 days. Group 
A: SMCs only. Group C: same side co-culture. Group D: opposite side co-culture (ref 20) 
to treat the acelluar matrix for bladder tissue engineering reconstruction in vitro (35). This 
method led to high porosity on the surface of the matrix with about 75% of normal strength. 
After 3-D dynamic culture, cells could penetrate deeper into the lamina propria of the 
matrix compared to untreated matrix. (Fig 14). The authors believe that treated scaffold 
might be more suitable for bladder tissue engineering reconstruction. In order to enhance 
the vascularization of tissue engineered bladder scaffold in vitro, Baumert et al. transferred 
the compound matrix into the greater omentum, which has been mentioned above (21). 
After meticulous investigation in vitro, Yoo, et al. used scaffold seeded with multiple cell 
types to reconstruct bladder tissue in 10 beagle dogs, which on which a partial cystectomy 
had been performed. As a result, 99% a increased in capacity was achieved in the 
reconstructed bladder. Immunocytochemical analyses confirmed the urothelial and muscle 
cell phenotypes and showed the presence of nerve fibers (36). Compared to the the 
technique of seeding with stromal cells, mesenchymal stem cell-seeded scaffold is becoming 
much more popular in bladder reconstruction. Chung et al. first performed bladder 
reconstruction using a BMSCs-seeded SIS in rats. At the level of gene expression, 
regenerated bladder was similar to the control bladder (37). Compared with the BMSCs, 
ADSCs can be procured more easily. Therefore, we chose ADSCs-seeded scaffolds for 
bladder reconstruction. At the end of 24 weeks after the operation, the reconstructed 
bladders reached a mean volume of 94.68±3.31% of the pre-cystectomy bladder capacity in 
our study. Smooth muscle cells, urothelium and nerve bundles could be detected by  
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Fig. 14. Cell penetration in 5% PAA-treated BSM in different speeds (0, 10 and 40 rpm) in 
three-dimensional dynamic culture. Smooth muscle cells and urothelial cell were seeded as 
layers and co-cultured on the submucosa side of 5% PAA-treated BSM using static culture 
(left column; a,b) and 3-D rotation culture conditions at 10 (middle column; c,d) and 40 rpm 
(right column; e,f). H&E staining (a,c,e) and DAPI staining (b,d,f) are shown at 200. 
Compared with static culture (left column), the cells grew uniformly with deeper 
penetration in the matrix using 3-D dynamic culture (middle and right column). The cells 
grown at 40 rpm had deeper penetration of cells within the matrix (e,f) compared to cells 
cultured at 10 rpm rotation speed (c,d) (ref 35) 
immunohistochemical assays. On the contrary, the mean bladder volume was 69.33±5.05% 
in the control group, made using unseeded scaffolds, and in these there was no evidence of 
organized muscle or nerve tissue (10) (Fig 15,16). In our study, we also noted that the 
optimal area for bladder regeneration using seeded scaffold is more than 40-60%, since 
smaller areas can be regenerated by native bladder tissue. These data provide a useful 
reference for further clinical application. Other stem cell-seeded scaffolds have also been 
reported for bladder reconstruction, such as hair-follicle stem cell-seeded scaffolds and 
urine-derived stem cell-seeded scaffolds (12). However, the number of reports is limited and 
the actual effectiveness of those scaffold need to be further studied.  
As well as traditional cell seeded scaffolds, many modification techniques have been used 
for tissue engineered bladder reconstructions in animal models. Gregory et al. seeded 
human adipose stem cells onto PLGA (85:15) bladder dome composites and grafted the 
result into rat hosts. Results showed that bladder capacity and compliance were maintained 
in the cell-seeded group throughout the 12 weeks (38) (Fig 17). SIS, modified by hyaluronic 
acid nanoparticles, has been used for bladder reconstruction. Urinary bladder augmentation 
has been performed in beagle dogs following hemi-cystectomy using nanoparticle-modified 
SIS. The results showed that the modified scaffold had significantly higher vascularity 
compared to unmodified one. This report demonstrated that the nanotechnology can 
represent a new approach for modifying biomaterials in bladder reconstruction (39). Wei et al. 
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Fig. 15. Cystographies of bladders reconstructed 4 weeks postoperatively. a The control 
group, b the experimental group 24 weeks postoperatively, c the experimental group and  
d the experimental group. Cystography demonstrated an improvement in both the shape 
and capacity of bladders reconstructed with seeded matrices 
 
Fig. 16. Histological features of the transplanted grafts. Four weeks postoperatively, native 
bladder tissue (blue arrow) and in the graft (yellow arrow). a The control group, b the 
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experimental group 24 weeks postoperatively, c in the control group there is no evidence of 
organized bladder tissue regeneration, d in the experimental group, the grafts had formed a 
multilayer epithelium with organized smooth muscle cells. Immunohistochemistry of the 
transplanted grafts. e Staining with cytokeratin AE1/AE3. -SM actin. g S-100 (arrows). 
 
Fig. 17. Construction of the three dimensional synthetic bladder composite. a: Schematic and 
b: gross micrograph of the three dimensional bladder composite. c:PLGA electropulled 
microfibers comprising the luminal layer. d: PLGA porous sponge was used as the outer 
layer (ref 38). 
designed a bioreactor to simulate the mechanical properties of bladder. This system 
successfully generated appropriate pressure waveforms. The viability of cells and tissue 
structures observed after culture in simulated conditions showed that mechanical 
stimulation improved the arrangement of cells on scaffold (24). 
3.1.2 Clinical application 
Although the reports about bladder reconstruction using tissue engineering techniques are 
few, they are the landmarks in tissue engineered lower urinary tract reconstruction. In 
Atala’s famous study, seven patients with myelomeningocele with high-pressure or poorly 
compliant bladders enrolled. Urothelial and muscle cells were seeded on a biodegradable 
bladder-shaped scaffold made of collagen and PGA. Then the biomaterial was used for 
reconstruction with an omental wrap (40). (Fig 18) After the operation, none of the 
ultrasounds showed any abnormalities. The cystogram showed the regular shape of bladder 
after the reconstruction. Urodynamic studies demonstrated significant improvement in 
volume and compliance in the composite engineered bladders (Fig 19). Postoperatively, it is 
difficult to distinguish the margin between the composite matrix and the native bladders 
grossly. All biopsies showed a trilayered structure, consisting of a urothelial cell-lined 
lumen surrounded by submucosa and muscle. During the post-operative follow-up period 
all patients had a stable renal function in which serum creatinine was similar to the 
preoperative status. No metabolic abnormalities were noted. There was no evidence of 
urinary calculi during the study.  
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Fig. 18. Construction of engineered bladder scaffold seeded with cells (A) and engineered 
bladder anastamosed to native bladder with running 4–0 polyglycolic sutures (B). Implant 
covered with fibrin glue and omentum (C) (Ref 40) 
 
 
Fig. 19. Preoperative (A) and 10-months postoperative (B) cystograms and urodynamic fi 
ndings in patient with a collagen-PGA scaff old engineered bladder (Ref 40) 
In another clinical study reported in the 2008 AUA, patients, who had received tissue 
engineered bladder showed increasing capacity and reduced intravesicular pressure. 
According to these reports, there is a clear reason to hope that the tissue engineered bladder 
can be utilized for a fully functioning neurogenic bladder. More indications about using this 
kind of biomaterial might be obtained in the near future. 
3.2 Urethral reconstruction 
The application of tissue engineering techniques for urethral reconstruction has been 
developed in recent years and the potential market for a tissue engineered solution for 
urethral stricture and abnormality will continue to increase in the near future. 
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3.2.1 Animal experiments 
In animal experiments addressing urethral reconstruction, the first attempts used 
biomaterials alone. Among these experiments, most papers reported the application of SIS 
in animal urethroplasty. Many results were encouraging. Regenerated urethra contained a 
well-differentiated epithelium, underneath which was circular smooth muscle and 
abundant collagen and fibrous connective tissue. The only difference between the SIS-
reconstructed urethra and normal urethra was the amount and size of the circular bundles 
of smooth muscle. However, several key points should be considered before using this kind 
of biomaterial. First, El-Assmy mentioned that locally prepared SIS and commercially 
available SIS may lead to the different results (41).This might be related to different pore 
sizes, which limit the infiltration and migration of cells. Second, the feasibility of using 
tabularized matrix for urethroplasty is still controversy although SIS has been proven to be 
useful for onlay urethroplasty. In Shokeir’s study, a 3cm segment of the whole urethral 
circumference was excised and replaced by a tube matrix of the same length and width in 14 
dogs. However, all dogs suffered a urethral fistula and/or stricture after the stent removal. 
This result demonstrated that a tube formed of matrix without seeded cells was not able to 
replace the long segment including the whole circumference of the canine urethra (42). 
Third, the length of urethral defect is another key point that should be considered during 
the urethroplasty. In order to investigate the maximum distance for normal tissue 
regeneration, Dorin et al. performed the tabularized urethroplasty in 12 male rabbits using 
acellular scaffold at varying lengths (0.5,1,2 and 3cm). The final result indicated that the 
maximal defect distance suitable for normal tissue formation using acellular grafts that rely 
on the native cells for tissue regeneration appears to be 0.5cm (43). Although other reports 
showed that the synthetic scaffold alone could be used for urethroplasty, the need ror a 
move to using cell-seeded scaffold is obvious. 
In 2003, Bhargava has developed tissue-engineered buccal mucosa for use in substitution 
urethroplasty. Histologically, the matrix closely resembled the native oral mucosa after 
culturing for 2 weeks. A gradually increasing thickness of the epidermis and remodeling 
of the dermis could also be seen (44) (Fig 20). Subsequently, more cell-seeded scaffolds 
were used for urethral reconstruction in our center. Li et al. replaced urinary epithelial 
cells with oral keratinocytes seeded on BAMG to reconstruct a tissue-engineered urethra. 
Histological results showed that multiple layers of keratinocytes had formed at 2 and 6 
months after the operation. Obvious margins between graft oral keratinocytes and host 
epithelium could be noticed in H&E sections (Fig 21b). Fu et al. used foreskin epidermal 
cell-seeded scaffolds to repair a urethra defect in a rabbit model. During following up, 
several layers of epidermal cells with abundant vessels in the submucosa were noticed. 
Moreover, immunofluorescence confirmed the survival of implanted epidermal cells at 1 
month after procedure (45,46) (Fig 21a). 
Recently, we have investigated the feasibility of constructing 3D structure urethra using 
multiple seeding cell types. It has also been hypothesized that building three-dimensional 
constructs in vitro prior to implantation would facilitate matrix vascularization in vivo and 
minimize the inflammatory response towards the matrix. Therefore, we seeded autologus 
corporal smooth muscle cells (CSMCs) and lingual keratinocytes into ACSM, using a static-
dynamic seeding method. After being cultured 14 days, 6 scaffolds with two kind of cells  
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Fig. 20. buccal mucosa culture at a, the air–liquid interface; b, submerged; c, at day 1 ALI;  
d, at day 5 ALI; e, at day 8 ALI and with f, Protocol 2 (cells on same surface) (Ref 44) 
 
Fig. 21. Histological results of tissue engineering urethral after reconstruction. a. tissue 
engineering urethra using foreskin seeded scaffold; B, tissue engineering urethra using oral 
keratinocytes seeded scaffold. (Ref 44,45) 
(Group C), 6 scaffolds with only lingual keratinocytes (Group B) and 6 matrices without 
cells (Group A) were used to repair a rabbit urethral defect. H&E staining of seeded ACSM 
showed several epithelial layers and well distributed CSMCs in the matrix. The maintenance 
of wide urethral caliber could be observed in Group C, while strictures were observed in 
groups A and B (Fig 22). Histologically, the retrieved urethra in group A showed fibrosis 
and inflammation during 6 months. A simple epithelial layer regenerated in group B but 
there was still no evidence of CSMCs growing into grafts during study period. A stratified 
epithelial layer and organized muscle fiber bundles were evident 6 months after 
implantation in group C (Fig 23). Our results demonstrated that lingual keratinocytes and 
CSMCs could be used as a source of seed cells for urethral tissue engineering. Using the 
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dynamic-static seeding method, a 3-D urethra could be constructed in vivo. It can provide 
us an alternative method to treat the urethral disease using tissue engineering techniquea. 
 
Fig. 22. Comparision of urethrography image in each group at 1,2,6 month after operation. 
The arrow indicates the stricture site of urethra 
 
Fig. 23. Macroscopic inspection and H&E staining (inset) of retrieved urethrae in each group 
at 1,2,6 month after operation. In group A, a urethral stricture existed at every study time 
point. H&E staining did not show continuous epithelial layers but did show severe 
inflammation. In group B, strictures could be noticed by gross inspection. Only 1-2 epithelial 
layers were formed at 6 months after implantation. In group C, patent lumens without 
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strictures could be observed by the end of 6 months. Meanwhile, multilayer squamous 
epithelial layers covered the surface of the urethra. 
 
Fig. 24. a. Tubular tissue was gently everted so that the mesothelium lined the lumen. b The 
everted tubular tissue was interposed and anastomosed as urethral graft (Ref 48) 
According to this result, the authors concluded that autologous tissue grown within the 
recipients’ peritoneal cavity can be used successfully for tabularized urethral reconstruction 
(48). In addition, synthetic matrix combined with seeded cells has also been used for 
urethroplasty. In Selim’s study, the optimal sterilization and cell seeding method for 
synthetic biomaterials in urethral reconstruction has been investigated. In their study, both 
PAA and γ-irradiation appear to be suitable methods for sterilizing PLGA scaffolds. And 
the sterilized PLGA 85:15 is a promising material for tissue engineering urethral 
reconstruction (49). 
3.2.2 Clinical application 
Up till now, many urologists have reported successful outcomes of urethral reconstruction 
using tissue engineering techniques. Most reports have been focused on treating urethral 
strictures using SIS. Among them, most results were satisfactory (Table 2) (50-56). In the 
report of Fiala et al., fifty patients with urethral strictures received urethroplasty using SIS. 
During post-operative follow-up, clinical, radiological, and cosmetic findings were excellent 
in 80% patients. No complications, such as fistulae, wound infections, or rejection were 
observed. This is so far the largest reports about using SIS for urethral reconstruction, in 
terms of numbers of patients. Their results were more satisfacory even than traditional 
urethral reconstruction using buccal or lingual mucosa for such low complication rate. In 
our center, we have also used SIS patch to undergo in 16 male patients with urethral 
strictures. The average length of strictures was 4.6 cm, ranging from 3.5-6 cm (Fig 25). After 
the operation, urethrography showed a wide patent urethra in all patients. The mean Qmax 
increased obviously from 3.8ml/s to 25ml/s. Only one patient needed urethral dilation due 
to the decreasing of Qmax at the end of 5 months. During follow-up, routine urethroscopy 
was performed in all patients. At the end of 4 weeks after operation, SIS could be easily 
noticed in the urethral lumen. However, the implanted graft could not be identified from 
the normal urethra 38 weeks after operation (Fig 26). The HE staining of biopsy showed that 
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stratified squamous epithelial layers had grown on the SIS implanted site, which was 
similar to normal urethral mucosa (Fig 27). According to these clinical experiences, the use 
of an acellular matrix SIS for urethroplasty should only be done when the length of urethral 
stricture is short. Patients with a bulbar urethral stricture are more suitable than those with a 
urethral stricture in other sites. Of course, the condition of urethral plate should also be 
considered before using SIS. We believe that urethroplasty using tissue engineered scaffold 
can achieve a satisfactory outcome that is similar to the gold-standard procedure provided 
optimal patients are selected.  
 
Table 2. Recoder of using SIS for urethral reconstruction in clinic 
 
Fig. 25. Application of SIS in urethroplasty.  
a. penile urethral stricture; b.bulbopenile urethral stricture; c.bulbar urethral stricture. 
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Fig. 26. Urethroscopy after the urethral reconstruction using SIS graft.Arrow headed the 
implanted site. a:4 weeks after op; b: 6 weeks after op; c: 38 weeks after operation. 
 
Fig. 27. The HE staining of biopsy showed that stratified squamous epithelial layers have 
grown on the SIS implanted site. 
Cell-seeded scaffolds have also been used for urethral reconstruction in some patients. 
Based on the previous reports mentioned above, Bhargava et al. useed autologous tissue-
engineered buccal mucosa to treat five patients with urethral strictures secondary to lichen 
sclerosis. After the intimal operation, one patient had complete excision of the grafted 
urethra and one required partial graft excision. The other three patients required some form 
of instrumentation although endoscopic appearance showed a patent urethra with the 
implanted graft in situ (57). Recently, Atala et al. reported that using cell-seeded synthetic 
tubularized scaffolds to repair urethral defects in five boys. At the end of follow-up, some 
satisfactory results were obtained. The median end Qmax was 27.1 ml/s, and serial 
urethrographic and endoscopic studies showed the maintenance of wide calibres without 
strictures (Fig 28) (58).  
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Fig. 28. A cell-seeded graft sutured to the normal urethral margins(Ref 59) 
4. Challenges and risks 
Based on previous studies, the potential market for a tissue-engineered solution for 
dysfunctional bladders and small contracted or inflamed bladders is probably far too small 
for commercial exploitation. The only two potential indications for commercial-scale tissue 
engineering lower urinary tract tissue are bladder carcinoma and urethral stricture. Cell- 
seeded scaffolds will probably be further investigated and applied in clinics. hree-
dimensional structures and the use of bioreactors will also be more and more popular in 
tissue engineering research for lower urinary tract reconstruction. 
However, several problems need to be solved. For example, the ethical problems about the 
implanted matrix (and where it is obtained) needs to be further discussed. The potential for 
carcinogenic problems arising form the use of stem cells is not clear. Optimal methods of cell 
labeling (for research) still needs to be improved. 
Nevertheless, there is no doubt that tissue engineering techniques for lower urinary tract 
reconstruction will themselves become the gold-standard in the near future. A substantial 
commercial market will continue to grow and more patients will obtain benefit from this 
technique. 
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